Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zhe-Cai Fan"'
Autor:
Shu‐Zhen Chen, Yan Ling, Le‐Xing Yu, Yu‐Ting Song, Xiao‐Fei Chen, Qi‐Qi Cao, Han Yu, Can Chen, Jiao‐Jiao Tang, Zhe‐Cai Fan, Yu‐Shan Miao, Ya‐Ping Dong, Jun‐Yan Tao, Satdarshan P.S. Monga, Wen Wen, Hong‐Yang Wang
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 4, Pp n/a-n/a (2021)
Abstract Background and aims 4‐phenylbutyric acid (4‐PBA) is a low molecular weight fatty acid that is used in clinical practice to treat inherited urea cycle disorders. In previous reports, it acted as a chemical chaperone inhibiting endoplasmic
Externí odkaz:
https://doaj.org/article/ecbc3e7c6c04480da20b47ca950361b5
Autor:
Qiqi Cao, Shuzhen Chen, Chunyu Wang, Yishan Zhong, Zhaofang Bai, Xinming Qi, Hongyang Wang, Huisi He, Wen Wen, Lingyan Xu, Xiaohe Xiao, Zhichao Jin, Guozhen Xing, Tao Luo, Xiu-Wu Bian, Lei Chen, Zhe-Cai Fan, Ya-Ping Dong, Jin Ren, Jiao Wang, Jia Ge, Zhixuan Li
Publikováno v:
Acta Pharmaceutica Sinica B. 12:2252-2267
Aristolochic acids (AAs) have long been considered as a potent carcinogen due to its nephrotoxicity. Aristolochic acid I (AAI) reacts with DNA to form covalent aristolactam (AL)–DNA adducts, leading to subsequent A to T transversion mutation, commo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5cd48fd2f06318112f67fca1e3eca36
https://doi.org/10.1016/j.apsb.2021.11.011
https://doi.org/10.1016/j.apsb.2021.11.011
Autor:
Ya-ping Dong, Shu-zhen Chen, Hui-si He, Zhuo-ran Sun, Li-xuan Jiang, Yan-qiu Gu, Ying Zhang, Fei Feng, Chun Chen, Zhe-cai Fan, Xiao-fei Chen, Wen Wen, Hong-yang Wang
Publikováno v:
Acta Pharmacologica Sinica.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69f53204ca6c74e3fabbaf68cf66ac19
https://doi.org/10.1038/s41401-023-01052-3
https://doi.org/10.1038/s41401-023-01052-3
Autor:
Wang Hongyang, Yushan Miao, Wen Wen, Ya-Ping Dong, Satdarshan P.S. Monga, Can Chen, Le-Xing Yu, Junyan Tao, Yan Ling, Xiao-Fei Chen, Qiqi Cao, Shuzhen Chen, Jiao-Jiao Tang, Zhe-Cai Fan, Han Yu, Yu-Ting Song
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 11, Iss 4, Pp n/a-n/a (2021)
Clinical and Translational Medicine, Vol 11, Iss 4, Pp n/a-n/a (2021)
Background and aims 4‐phenylbutyric acid (4‐PBA) is a low molecular weight fatty acid that is used in clinical practice to treat inherited urea cycle disorders. In previous reports, it acted as a chemical chaperone inhibiting endoplasmic reticulu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64dabdc452db9a1f33956eae781f49c4
http://europepmc.org/articles/PMC8087947
http://europepmc.org/articles/PMC8087947